Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines

International Immunology

Volumn 11, Issue 7, 1999, Pages 1103-1110

  Ghosh, Souravi ^a   Jackson, David C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Immunocastration; Luteinizing hormone releasing hormone; Synthetic vaccine

Indexed keywords

ANTIBODY; CONTRACEPTIVE VACCINE; GONADORELIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE STERILITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ANTIGENS; CONTRACEPTION, IMMUNOLOGIC; EPITOPES; EPITOPES, T-LYMPHOCYTE; FEMALE; GONADOTROPIN-RELEASING HORMONE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, HELPER-INDUCER; THYROXINE; VACCINES, SYNTHETIC;

EID: 0032811069     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.7.1103     Document Type: Article

References (35)

1. Fraser, H. M., Gunn, A., Jeffcoate, S. L. and Holland, D. T. 1974. Effect of active immunization to luteinizing hormone releasing hormone on serum and pituitary gonadotrophins, testes and accessory sex organs in the male rat. J. Endocrinol. 63:399.
2. Fraser, H. M. and Baker, T. G. 1978. Changes in the ovaries of rats after immunization against luteinizing hormone releasing hormone. J. Endocrinol. 77:85.
3. Falvo, R. E., Chandrashekar, V., Arthur, R. D., Kuenstler, A. R., Hasson, T., Awoniyi, C. and Schanbacher, B. D. 1986. Effect of active immunization against LHRH or LH in boars: reproductive consequences and performance traits. J. Anim. Sci. 63:986.
4. Hoskinson, R. M., Rigby, R. D., Mattner, P. E., Huynh, V. L., D'Occhio, M., Neish, A., Trigg, T. E., Moss, B. A., Lindsey, M. J., Coleman, G. D., et al. 1990. Vaxstrate: an anti-reproductive vaccine for cattle. Aust. J. Biotechnol. 4:166.
5. Talwar, G. P., Singh, O., Pal, R. and Chatterjee, N. 1992. Vaccines for control of fertility and hormone dependent cancers. Int. J. Immunopharmacol. 14:511.
6. Rovan, E., Fiebiger, E., Kalla, N. R., Talwar, G. P., Aulitzky, W. and Frick, J. 1992. Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat. Urol. Res. 20:323.
7. Oonk, H. B., Turkstra, J. A., Schaaper, W. M., Erkens, J. H., Weerd, M. H., van Nes, A., Verheijden, J. H. and Meloen, R. H. 1998. New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH [in process citation]. Vaccine 16:1074.
8. Audibert, F. a. C. L. 1984. Modern Approaches to Vaccines. Molecular and Chemical Basis of Virus Virulence and Immunogenicity. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
9. Herzenberg, L. A. and Tokuhisa, T. 1980. Carrier-priming leads to hapten-specific suppression. Nature 285:664.
10. Schutze, M. P., Leclerc, C., Jolivet, M., Audibert, F. and Chedid, L. 1985. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol. 135:2319.
11. Etlinger, H. M., Felix, A. M., Gillessen, D., Heimer, E. P., Just, M., Pink, J. R., Sinigaglia, F., Sturchler, D., Takacs, B., Trzeciak, A., et al. 1988. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J. Immunol. 140:626.
12. Etlinger, H. M. and Knorr, R. 1991. Model using a peptide with carrier function for vaccination against different pathogens. Vaccine 9:512.
13. Kumar, A., Arora, R., Kaur, P., Chauhan, V. S. and Sharma, P. 1992. 'Universal' T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J. Immunol. 148:1499.
14. Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237.
15. Ho, P. C., Mutch, D. A., Winkel, K. D., Saul, A. J., Jones, G. L., Doran, T. J. and Rzepczyk, C. M. 1990. Identification of two promiscuous T cell epitopes from tetanus toxin. Eur. J. Immunol. 20:477.
16. Tindle, R. W., Fernando, G. J., Sterling, J. C. and Frazer, I. H. 1991. A 'public' T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc. Natl Acad. Sci. USA 88:5887.
17. Fern, J. and Good, M. F. 1992. Promiscuous malaria peptide epitope stimulates CD45Ra T cells from peripheral blood of nonexposed donors. J. Immunol. 148:907.
18. Silversides, D. W., Allen, A. F., Misra, V., Qualtiere, L., Mapletoft, R. J. and Murphy, B. D. 1988. A synthetic luteinizing hormone releasing hormone vaccine. I. Conjugation and specificity trials in BALB/c mice. J. Reprod. Immunol. 13:249.
19. Ladd, A., Tsong, Y. Y., Lok, J. and Thau, R. B. 1990. Active immunization against LHRH: I. Effects of conjugation site and dose. Am. J. Reprod. Immunol. 22:56.
20. Fitzmaurice, C. J., Brown, L. E., Mclnerney, T. L. and Jackson, D. C. 1996. The assembly and immunological properties of non-linear synthetic immunogens containing T cell and B cell determinants. Vaccine 14:553.
21. Hancock, W. S. and Battersby, J. E. 1976. A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzenesulphonic acid. Anal Biochem 71:260.
22. Valmori, D., Pessi, A., Bianchi, E. and Corradin, G. 1992. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. 149:717.
23. Russell-Jones, G. J., Sullivan, J. S. and Geczy, A. F. 1993. Peptide sequences with strong stimulatory activity for lymphoid cells: implications for vaccine development. Vaccine 11:1310.
24. + T cells within the light chain of the H3 hemagglutinin molecule of influenza virus. Virology 198:613.
25. Julius, M. H., Simpson, E. and Herzenberg, L A. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645.
26. d-restricted T cell clones within antigenic site E on influenza virus hemagglutinin. J. Virol 62:305.
27. Macdonald, R. A., Hosking, C. S. and Jones, C. L. 1988. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J. Immunol. Methods 106:191.
28. Partidos, C. D., Obeid, O. E. and Steward, M. W. 1992. Antibody responses to non-immunogenic synthetic peptides induced by coimmunization with immunogenic peptides. Immunology 77:262.
29. Partidos, C., Stanley, C. and Steward, M. 1992. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. Eur. J. Immunol. 22:2675.
30. Fernandez, I. M., Snijders, A., Benaissa-Trouw, B. J., Harmsen, M., Snippe, H. and Kraaijeveld, C. A. 1993. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus. J. Virol 67:5843.
31. Shaw, D. M., Stanley, C. M., Partidos, C. D. and Steward, M. W. 1993. Influence of the T-helper epitope on the titer and affinity of antibodies to B-cell epitopes after co-immunization. Mol. Immunol. 30:961.
32. Silversides, D. W., Allen, A. F., Misra, V., Murphy, B. D. and Mapletoft, R. J. 1988. A synthetic luteinizing hormone releasing hormone vaccine II. Temporal aspects of titer development and formulation trials in BALB/c mice. J. Reprod. Immunol. 14:47.
33. Meloen, R. H., Turkstra, J. A., Lankhof, H., Puijk, W. C., Schaaper, W. M., Dijkstra, G., Wensing, C. J. and Oonk, R. B. 1994. Efficient immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like peptide [published erratum appears in Vaccine 1994; 12(12): 1152]. Vaccine 12:741.
34. Sad, S., Chauhan, V. S., Arunan, K. and Raghupathy, R. 1993. Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes. Vaccine 11:1145.
35. Ferro, V. A. and Stimson, W. H. 1998. Investigation into suitable carrier molecules for use in an anti-gonadotrophin releasing hormone vaccine [in process citation]. Vaccine 16:1095.